With the broadening of its Digital Cash technology to support secure Host-based Card Emulation (HCE)...
Windon Energy Group meddelade den 27 mars år 2024 att bolaget har ingått ett partnerskap i Norge med...
Redeye comments on Wyld’s Q4 2023 report, which fell short of expectations.
Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is goin...
Redeye comments on the news that Alzecure has announced a rights issue of up to SEK68m in total.
Bolaget presenterar vägen framåt I samband med bolagets kapitalmarknadsdag presenterades nya finansi...
Redeye gives an additional comment on the written minutes from the FDA following the end of phase II...
Sivers has announced the resignation of CEO Anders Strom, who is leaving his position to pursue new ...
Smart Eye’s CEO Martin Krantz and CFO Mats Benjaminsson presented the background and purpose of the ...
Redeye briefly comments on BeammWave's rights issue.
Redeye has commented on BeammWave's capital raise, which aims to secure SEK39.
Inga större ordrar under Q1’24 och tuffa jämförelsetal Under H1’24 möter MilDef tuffa jämförelsetal.
Redeye gives its estimate changes in Smart Eye following the recent news flow in the company.
Redeye updates its estimates and fair value range following Energy Save’s Q3 2023/2024 report.
Redeye updates its view on CI Games post its release of Lords of the Fallen.
Redeye leaves a comment following the Magle Group’s announced public offer to acquire Amniotics earl...
Redeye endorses the outcome of IRLAB’s end of phase II meeting with the FDA, including the recently ...
Movinn published on March 22nd the company’s Annual Report for 2023.
Earlier today, Coala-Life announced the board’s decision to file for bankruptcy.
Redeye comments on the public offer to acquire Amniotics and the short-term capital obtained yesterd...
